2021
DOI: 10.1016/j.wneu.2021.03.027
|View full text |Cite
|
Sign up to set email alerts
|

Clinical and Neuroimaging Features of Magnetic Resonance−Guided Stereotactic Laser Ablation for Newly Diagnosed and Recurrent Pediatric Brain Tumors: A Single Institutional Series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(9 citation statements)
references
References 13 publications
0
9
0
Order By: Relevance
“…In our series, we observed no mortality or long-term morbidity. Ahluwalia et al (13) stated that "no unanticipated adverse events occurred" in their adult series. The complications reported have primarily been bleeding, transient or permanent deficits related to proximity to eloquent areas, and edema, with no significant differences in adults and pediatric series (3,(6)(7)(8)(9)(10)(13)(14)(15)(16)(17).…”
Section: Discussionmentioning
confidence: 99%
“…In our series, we observed no mortality or long-term morbidity. Ahluwalia et al (13) stated that "no unanticipated adverse events occurred" in their adult series. The complications reported have primarily been bleeding, transient or permanent deficits related to proximity to eloquent areas, and edema, with no significant differences in adults and pediatric series (3,(6)(7)(8)(9)(10)(13)(14)(15)(16)(17).…”
Section: Discussionmentioning
confidence: 99%
“…In the pediatric population, Pehlivan et al assessed the application of LITT as safe and efficient in 4 children with LGG whose seizure presentations either improved significantly or resolved entirely. Among other tumor entities included in the study, LITT yielded the most significant effects in LGG [ 25 ]. A case series of 8 children with LGG reported significant cytoreductive effects 15 to 36 months after LITT ablation [ 55 ].…”
Section: Discussionmentioning
confidence: 99%
“…While progression-free survival (PFS) analyses for default treatment options such as surgical resection (5.5 to 6.2 years) [ 17 , 18 ], SRS (3.4 to 5.3 years) [ 19 , 20 , 21 , 22 ], and iMRT [ 23 ] have been studied largely, survival outcomes after LITT treatment in LGG remain limitedly available at this time [ 24 , 25 ]. Only one study presented by Leonardi et al evaluated survival outcomes after LITT in a larger-scale adult case series comprising 7 recurrent low-grade astrocytomas, reporting a mean overall survival (OS) of 144 months after diagnosis and 34 months after LITT, and a mean PFS of 16 months after LITT [ 24 ].…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations